Surveillance of pyrazinamide susceptibility among multidrug-resistant <it>Mycobacterium tuberculosis </it>isolates from Siriraj Hospital, Thailand

Surveillance of pyrazinamide susceptibility among multidrug-resistant <it>Mycobacterium tuberculosis </it>isolates from Siriraj Hospital, Thailand

<p>Abstract</p> <p>Background</p> <p>Susceptibility testing of pyrazinamide (PZA) against <it>Mycobacterium tuberculosis </it>is difficult to perform because the acidity of culture medium that is required for drug activity also inhibits the growth of bacteri...

Full description

Bibliographic Details
Main Authors:	Jonmalung Jirarut, Prammananan Therdsak, Leechawengwongs Manoon, Chaiprasert Angkana
Format:	Article
Language:	English
Published:	BMC 2010-08-01
Series:	BMC Microbiology
Online Access:	http://www.biomedcentral.com/1471-2180/10/223

Similar Items

Correction: Surveillance of pyrazinamide susceptibility among multidrug-resistant <it>Mycobacterium tuberculosis </it>isolates from Siriraj Hospital, Thailand
by: Leechawengwongs Manoon, et al.
Published: (2010-11-01)

Intact pks15/1 in Non–W-Beijing Mycobacterium tuberculosis Isolates
by: Angkana Chaiprasert, et al.
Published: (2006-05-01)

Overexpression of eis without a mutation in promoter region of amikacin- and kanamycin-resistant Mycobacterium tuberculosis clinical strain
by: Angkanang Sowajassatakul, et al.
Published: (2018-07-01)

Distribution of Drug-Resistant Genes Among Thai Multidrug-Resistant Mycobacterium Tuberculosis (MDR-TB) Clinical Isolates
by: Therdsak Prammananan
Published: (2020-04-01)

Rapid Molecular Detection of Multidrug-Resistant Tuberculosis by PCR-Nucleic Acid Lateral Flow Immunoassay.
by: Hatairat Kamphee, et al.
Published: (2015-01-01)

Disseminated Mycobacterium tuberculosis in Imported Sooty Mangabey, Thailand
by: Sawang Kesdangsakonwut, et al.
Published: (2015-03-01)

Six-year Report of Mycobacteria Recovered from Automated culture System at Siriraj Hospital
by: Angkana Chaiprasert, et al.
Published: (2004-09-01)

Susceptibility of Mycobacterium tuberculosis to Non-Toxic Level Ozone
by: Popchai Ngamskulrungroj, et al.
Published: (2006-01-01)

Polymorphisms in drug-resistant-related genes shared among drug-resistant and pan-susceptible strains of sequence type 10, Beijing family of Mycobacterium tuberculosis
by: Sanjib Mani Regmi, et al.
Published: (2015-01-01)

An Agar Medium Designed for Pyrazinamide Susceptibility Testing Of the Mycobacterium Tuberculosis Strains
by: M Najafi Mosleh, et al.
Published: (2007-06-01)

An Agar Medium Designed for Pyrazinamide Susceptibility Testing Of the Mycobacterium Tuberculosis Strains
by: M Najafi Mosleh, et al.
Published: (2007-03-01)

Value of pyrazinamide for composition of new treatment regimens for multidrug-resistant Mycobacterium tuberculosis in China
by: Hui Xia, et al.
Published: (2020-01-01)

Detection of pyrazinamide heteroresistance in Mycobacterium tuberculosis
by: Mikaela Glader, et al.
Published: (2015-01-01)

Genetic signatures of Mycobacterium tuberculosis Nonthaburi genotype revealed by whole genome analysis of isolates from tuberculous meningitis patients in Thailand
by: Olabisi Oluwabukola Coker, et al.
Published: (2016-04-01)

Pyrazinamide Resistance and Mutation Patterns Among Multidrug-Resistant Mycobacterium tuberculosis from Henan Province
by: Shi J, et al.
Published: (2020-08-01)

Molecular characterization of pyrazinamide resistance in Mycobacterium tuberculosis
by: Ko, Wai-ting, et al.
Published: (2014)

Characterization of pyrazinamide resistance in consecutive multidrug-resistant mycobacterium tuberculosis isolates in sweden between 2003 and 2015
by: Mikael Mansjo, et al.
Published: (2017-01-01)

Phenotypic and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates in Ningbo, China
by: Yang Che, et al.
Published: (2021-06-01)

Pyrazinamide resistance in Swedish multidrug-resistant tuberculosis 2003–2013
by: M Mansjö, et al.
Published: (2015-01-01)

Determination of pyrazinamide plasma concentrations using lc-ms and pharmacokinetics of pyrazinamide in patients with multidrug-resistant tuberculosis and in patients co-infected with multidrug-resistant tuberculosis and HIV
by: Botha, Carla Ilse
Published: (2014)

Host targeted activity of pyrazinamide in Mycobacterium tuberculosis infection.
by: Claudia Manca, et al.
Published: (2013-01-01)

An improved method for detection of pyrazinamide resistance in Mycobacterium tuberculosis
by: Amani Alnimr, et al.
Published: (2012-01-01)

Prevalence and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Southern China
by: Yu Pang, et al.
Published: (2017-11-01)

Detection of Novel Gene Mutations Associated with Pyrazinamide Resistance in Multidrug-Resistant Mycobacterium tuberculosis Clinical Isolates in Southern China
by: Hameed HMA, et al.
Published: (2020-01-01)

The molecular basis of pyrazinamide activity on Mycobacterium tuberculosis PanD
by: Qingan Sun, et al.
Published: (2020-01-01)

The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in <it>Mycobacterium tuberculosis</it>
by: Parsons Linda M, et al.
Published: (2001-04-01)

Association between genotypic and phenotypic pyrazinamide resistance in Mycobacterium tuberculosis
by: M.G. Whitfield, et al.
Published: (2014-04-01)

Intracellular localisation of Mycobacterium tuberculosis affects efficacy of the antibiotic pyrazinamide
by: Pierre Santucci, et al.
Published: (2021-06-01)

In Vitro Activities of Enantiopure and Racemic 1′-Acetoxychavicol Acetate against Clinical Isolates of Mycobacterium tuberculosis
by: Saradee Warit, et al.
Published: (2017-09-01)

Transcriptional response to the host cell environment of a multidrug-resistant Mycobacterium tuberculosis clonal outbreak Beijing strain reveals its pathogenic features
by: Pakorn Aiewsakun, et al.
Published: (2021-02-01)

Design, synthesis and biological activity of pyrazinamide derivatives for anti-Mycobacterium tuberculosis
by: Shiyang Zhou, et al.
Published: (2017-01-01)

Whole-Genome Sequencing Analysis of Serially Isolated Multi-Drug and Extensively Drug Resistant Mycobacterium tuberculosis from Thai Patients.
by: Kiatichai Faksri, et al.
Published: (2016-01-01)

Future Trend in Laboratory Diagnosis of Tuberculosis
by: Angkana Chaiprasert
Published: (2009-01-01)

Crystal structure of the pyrazinamidase of Mycobacterium tuberculosis: insights into natural and acquired resistance to pyrazinamide.
by: Stéphanie Petrella, et al.
Published: (2011-01-01)

Pyrazinamide resistance, Mycobacterium tuberculosis lineage and treatment outcomes in San Francisco, California.
by: Jonathan M Budzik, et al.
Published: (2014-01-01)

Pyrazinamide resistance and the pncA gene variability in mycobacterium tuberculosis and related bacteria
by: Bamaga, Mohammad Salih
Published: (2005)

Chemotherapy of TB and M/XDR-TB
by: Manoon Leechawengwongs
Published: (2009-01-01)

PYRAZINAMIDE/PYRAZINOIC ACID RESISTANCE IN MYCOBACTERIUM TUBERCULOSIS: RECENT FINDINGS AND IMPLICATIONS FOR IMPROVING THE TREATMENT OF TUBERCULOSIS
by: R. M. Anthony, et al.
Published: (2018-12-01)

Estimation of pyrazinamidase activity using a cell-free In vitro synthesis of pnca and its association with pyrazinamide susceptibility in Mycobacterium tuberculosis
by: Daniel Rueda, et al.
Published: (2018-01-01)

Molecular Identification of Mutations Associated with Pyrazinamide-Resistance in Multidrug-Resistant Tuberculosis in Eight Provinces of Iran
by: Jila Moradi, et al.
Published: (2017-11-01)